Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #65
2378
mi
from 98109
Skillman, NJ
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #65
2378
mi
from 98109
Skillman, NJ
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #7
2262
mi
from 98109
New York, NY
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #7
2262
mi
from 98109
New York, NY
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #41
2271
mi
from 98109
Clemmons, NC
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #41
2271
mi
from 98109
Clemmons, NC
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #45
2362
mi
from 98109
Raleigh, NC
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #45
2362
mi
from 98109
Raleigh, NC
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #31
1967
mi
from 98109
Cincinnati, OH
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #31
1967
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #95
2008
mi
from 98109
Columbus, OH
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #95
2008
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #24
1998
mi
from 98109
Hilliard, OH
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #24
1998
mi
from 98109
Hilliard, OH
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #61
2019
mi
from 98109
Middleburg Heights, OH
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #61
2019
mi
from 98109
Middleburg Heights, OH
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #73
1920
mi
from 98109
Toledo, OH
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #73
1920
mi
from 98109
Toledo, OH
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #14
1517
mi
from 98109
Edmond, OK
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #14
1517
mi
from 98109
Edmond, OK
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #15
1522
mi
from 98109
Oklahoma City, OK
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #15
1522
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #37
249
mi
from 98109
Eugene, OR
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #37
249
mi
from 98109
Eugene, OR
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #40
367
mi
from 98109
Medford, OR
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #40
367
mi
from 98109
Medford, OR
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #58
149
mi
from 98109
Portland, OR
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #58
149
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #26
2487
mi
from 98109
Warwick, RI
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #26
2487
mi
from 98109
Warwick, RI
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #69
2226
mi
from 98109
Greenville, SC
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #69
2226
mi
from 98109
Greenville, SC
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #22
2242
mi
from 98109
Spartanburg, SC
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #22
2242
mi
from 98109
Spartanburg, SC
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #19
1908
mi
from 98109
Smyrna, TN
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #19
1908
mi
from 98109
Smyrna, TN
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #27
1758
mi
from 98109
Boerne, TX
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #27
1758
mi
from 98109
Boerne, TX
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #75
1680
mi
from 98109
Dallas, TX
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #75
1680
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #49
1377
mi
from 98109
El Paso, TX
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #49
1377
mi
from 98109
El Paso, TX
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #44
1890
mi
from 98109
Houston, TX
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #44
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #77
1659
mi
from 98109
Lewisville, TX
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #77
1659
mi
from 98109
Lewisville, TX
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #87
1667
mi
from 98109
Plano, TX
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #87
1667
mi
from 98109
Plano, TX
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #29
1778
mi
from 98109
San Antonio, TX
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #29
1778
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #42
707
mi
from 98109
West Jordan, UT
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #42
707
mi
from 98109
West Jordan, UT
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #39
2329
mi
from 98109
South Burlington, VT
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #39
2329
mi
from 98109
South Burlington, VT
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #9
2339
mi
from 98109
Henrico, VA
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #9
2339
mi
from 98109
Henrico, VA
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #88
2350
mi
from 98109
Richmond, VA
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #88
2350
mi
from 98109
Richmond, VA
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #76
27
mi
from 98109
Tacoma, WA
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #76
27
mi
from 98109
Tacoma, WA
Click here to add this to my saved trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated:  1/19/2018
Roxane Laboratories Research Site #82
1683
mi
from 98109
Greenfield, WI
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared With Advair Diskus® 100/50 in Subjects With Asthma
Status: Enrolling
Updated: 1/19/2018
Roxane Laboratories Research Site #82
1683
mi
from 98109
Greenfield, WI
Click here to add this to my saved trials
Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fed Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Montelukast Sodium 5 mg Chewable Tablets Under Fed Conditions
Status: Enrolling
Updated:  1/19/2018
PRACS Institute, Ltd.
1190
mi
from 98109
Fargo, ND
Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fed Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Montelukast Sodium 5 mg Chewable Tablets Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
PRACS Institute, Ltd.
1190
mi
from 98109
Fargo, ND
Click here to add this to my saved trials
Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fasted Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Montelukast Sodium 5 mg Chewable Tablets Under Fasted Conditions
Status: Enrolling
Updated:  1/19/2018
PRACS Institute, Ltd.
1190
mi
from 98109
Fargo, ND
Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fasted Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Montelukast Sodium 5 mg Chewable Tablets Under Fasted Conditions
Status: Enrolling
Updated: 1/19/2018
PRACS Institute, Ltd.
1190
mi
from 98109
Fargo, ND
Click here to add this to my saved trials
Bioequivalency Study of Montelukast 10 mg Tablets Under Fed Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Montelukast Sodium 10 mg Tablets Under Fed Conditions
Status: Enrolling
Updated:  1/19/2018
PRACS Institute, Ltd.
1190
mi
from 98109
Fargo, ND
Bioequivalency Study of Montelukast 10 mg Tablets Under Fed Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Montelukast Sodium 10 mg Tablets Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
PRACS Institute, Ltd.
1190
mi
from 98109
Fargo, ND
Click here to add this to my saved trials
Bioequivalency Study of Montelukast 10 mg Tablets Under Fasted Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Montelukast Sodium 10 mg Tablets Under Fasted Conditions
Status: Enrolling
Updated:  1/19/2018
PRACS Institute, Ltd.
1190
mi
from 98109
Fargo, ND
Bioequivalency Study of Montelukast 10 mg Tablets Under Fasted Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Montelukast Sodium 10 mg Tablets Under Fasted Conditions
Status: Enrolling
Updated: 1/19/2018
PRACS Institute, Ltd.
1190
mi
from 98109
Fargo, ND
Click here to add this to my saved trials
Informed Consent Formats by Information Preference and Priority
Informed Consent Formats by Information Preference and Priority
Status: Enrolling
Updated:  1/24/2018
Carnegie Mellon University
2134
mi
from 98109
Pittsburgh, PA
Informed Consent Formats by Information Preference and Priority
Informed Consent Formats by Information Preference and Priority
Status: Enrolling
Updated: 1/24/2018
Carnegie Mellon University
2134
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
Supporting Asthma Management Behaviors in Aging Adults
Clinic-based vs. Home-based Support to Improve Care and Outcomes for Older Asthmatics
Status: Enrolling
Updated:  2/2/2018
Institute for Family Health
2401
mi
from 98109
New York, NY
Supporting Asthma Management Behaviors in Aging Adults
Clinic-based vs. Home-based Support to Improve Care and Outcomes for Older Asthmatics
Status: Enrolling
Updated: 2/2/2018
Institute for Family Health
2401
mi
from 98109
New York, NY
Click here to add this to my saved trials
Supporting Asthma Management Behaviors in Aging Adults
Clinic-based vs. Home-based Support to Improve Care and Outcomes for Older Asthmatics
Status: Enrolling
Updated:  2/2/2018
Mount Sinai-St. Luke's Roosevelt Hospital Center
2400
mi
from 98109
New York, NY
Supporting Asthma Management Behaviors in Aging Adults
Clinic-based vs. Home-based Support to Improve Care and Outcomes for Older Asthmatics
Status: Enrolling
Updated: 2/2/2018
Mount Sinai-St. Luke's Roosevelt Hospital Center
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
Supporting Asthma Management Behaviors in Aging Adults
Clinic-based vs. Home-based Support to Improve Care and Outcomes for Older Asthmatics
Status: Enrolling
Updated:  2/2/2018
Icahn School of Medicine at Mount Sinai
mi
from 98109
New York, NY
Supporting Asthma Management Behaviors in Aging Adults
Clinic-based vs. Home-based Support to Improve Care and Outcomes for Older Asthmatics
Status: Enrolling
Updated: 2/2/2018
Icahn School of Medicine at Mount Sinai
mi
from 98109
New York, NY
Click here to add this to my saved trials
Title: Comparative Effectiveness of Asthma Interventions Within an AHRQ PBRN
Accelerating Implementation of Comparative Effectiveness Findings on Clinical and Delivery Systems by Leveraging AHRQ Networks
Status: Enrolling
Updated:  2/4/2018
Department of Family Medicine
2283
mi
from 98109
Charlotte, NC
Title: Comparative Effectiveness of Asthma Interventions Within an AHRQ PBRN
Accelerating Implementation of Comparative Effectiveness Findings on Clinical and Delivery Systems by Leveraging AHRQ Networks
Status: Enrolling
Updated: 2/4/2018
Department of Family Medicine
2283
mi
from 98109
Charlotte, NC
Click here to add this to my saved trials
Title: Comparative Effectiveness of Asthma Interventions Within an AHRQ PBRN
Accelerating Implementation of Comparative Effectiveness Findings on Clinical and Delivery Systems by Leveraging AHRQ Networks
Status: Enrolling
Updated:  2/4/2018
CMC Elizabeth Family Medicine
2283
mi
from 98109
Charlotte, NC
Title: Comparative Effectiveness of Asthma Interventions Within an AHRQ PBRN
Accelerating Implementation of Comparative Effectiveness Findings on Clinical and Delivery Systems by Leveraging AHRQ Networks
Status: Enrolling
Updated: 2/4/2018
CMC Elizabeth Family Medicine
2283
mi
from 98109
Charlotte, NC
Click here to add this to my saved trials
Subcutaneous Immunotherapy for Mouse in Adults
A Biomarker-Based Pilot Study of Mouse Subcutaneous Immunotherapy in Mouse Sensitive Adults With Asthma and/or Perennial Allergic Rhinitis (ICAC-26)
Status: Enrolling
Updated:  2/5/2018
Children's National Health System
2321
mi
from 98109
Washington,
Subcutaneous Immunotherapy for Mouse in Adults
A Biomarker-Based Pilot Study of Mouse Subcutaneous Immunotherapy in Mouse Sensitive Adults With Asthma and/or Perennial Allergic Rhinitis (ICAC-26)
Status: Enrolling
Updated: 2/5/2018
Children's National Health System
2321
mi
from 98109
Washington,
Click here to add this to my saved trials
Subcutaneous Immunotherapy for Mouse in Adults
A Biomarker-Based Pilot Study of Mouse Subcutaneous Immunotherapy in Mouse Sensitive Adults With Asthma and/or Perennial Allergic Rhinitis (ICAC-26)
Status: Enrolling
Updated:  2/5/2018
Ann & Robert Lurie Children's Hospital of Chicago
1733
mi
from 98109
Chicago, IL
Subcutaneous Immunotherapy for Mouse in Adults
A Biomarker-Based Pilot Study of Mouse Subcutaneous Immunotherapy in Mouse Sensitive Adults With Asthma and/or Perennial Allergic Rhinitis (ICAC-26)
Status: Enrolling
Updated: 2/5/2018
Ann & Robert Lurie Children's Hospital of Chicago
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Subcutaneous Immunotherapy for Mouse in Adults
A Biomarker-Based Pilot Study of Mouse Subcutaneous Immunotherapy in Mouse Sensitive Adults With Asthma and/or Perennial Allergic Rhinitis (ICAC-26)
Status: Enrolling
Updated:  2/5/2018
Johns Hopkins Children's Center: Department of Allergy & Immunology
2329
mi
from 98109
Baltimore, MD
Subcutaneous Immunotherapy for Mouse in Adults
A Biomarker-Based Pilot Study of Mouse Subcutaneous Immunotherapy in Mouse Sensitive Adults With Asthma and/or Perennial Allergic Rhinitis (ICAC-26)
Status: Enrolling
Updated: 2/5/2018
Johns Hopkins Children's Center: Department of Allergy & Immunology
2329
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Subcutaneous Immunotherapy for Mouse in Adults
A Biomarker-Based Pilot Study of Mouse Subcutaneous Immunotherapy in Mouse Sensitive Adults With Asthma and/or Perennial Allergic Rhinitis (ICAC-26)
Status: Enrolling
Updated:  2/5/2018
Henry Ford Health System: Division of Allergy and Immunology
1931
mi
from 98109
Detroit, MI
Subcutaneous Immunotherapy for Mouse in Adults
A Biomarker-Based Pilot Study of Mouse Subcutaneous Immunotherapy in Mouse Sensitive Adults With Asthma and/or Perennial Allergic Rhinitis (ICAC-26)
Status: Enrolling
Updated: 2/5/2018
Henry Ford Health System: Division of Allergy and Immunology
1931
mi
from 98109
Detroit, MI
Click here to add this to my saved trials
Asthma Controller Adherence After Hospitalization
Automated Adherence Feedback for High Risk Children With Asthma
Status: Enrolling
Updated:  2/7/2018
Children's Hospital of Philadelphia
2373
mi
from 98109
Philadelphia, PA
Asthma Controller Adherence After Hospitalization
Automated Adherence Feedback for High Risk Children With Asthma
Status: Enrolling
Updated: 2/7/2018
Children's Hospital of Philadelphia
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Iggy and the Inhalers: A Study to Assess the Impact of an Asthma Education Program in School Age Children
Iggy and the Inhalers: A Pilot Study to Assess the Impact of an Asthma Education Program in School Age Children
Status: Enrolling
Updated:  2/7/2018
Yacktman Pediatrics
1718
mi
from 98109
Park Ridge, IL
Iggy and the Inhalers: A Study to Assess the Impact of an Asthma Education Program in School Age Children
Iggy and the Inhalers: A Pilot Study to Assess the Impact of an Asthma Education Program in School Age Children
Status: Enrolling
Updated: 2/7/2018
Yacktman Pediatrics
1718
mi
from 98109
Park Ridge, IL
Click here to add this to my saved trials
Effectiveness of the Propeller Health (Formerly Asthmapolis) Monitoring System
Effectiveness of the Propeller Health (Formerly Asthmapolis) Monitoring System
Status: Enrolling
Updated:  2/9/2018
Woodland Medical Center
619
mi
from 98109
Woodland, CA
Effectiveness of the Propeller Health (Formerly Asthmapolis) Monitoring System
Effectiveness of the Propeller Health (Formerly Asthmapolis) Monitoring System
Status: Enrolling
Updated: 2/9/2018
Woodland Medical Center
619
mi
from 98109
Woodland, CA
Click here to add this to my saved trials
An Observational Study of the Use and Safety of Xolair® During Pregnancy
The Xolair® Pregnancy Registry: An Observational Study of the Use and Safety of Xolair® (Omalizumab) During Pregnancy
Status: Enrolling
Updated:  2/12/2018
Ppd Development, Llc
2350
mi
from 98109
Morrisville, NC
An Observational Study of the Use and Safety of Xolair® During Pregnancy
The Xolair® Pregnancy Registry: An Observational Study of the Use and Safety of Xolair® (Omalizumab) During Pregnancy
Status: Enrolling
Updated: 2/12/2018
Ppd Development, Llc
2350
mi
from 98109
Morrisville, NC
Click here to add this to my saved trials
A Community Health Worker Home Intervention to Improve Pediatric Asthma Outcomes
A Randomized Controlled Trial of a Community Health Worker Home-Based Asthma Intervention
Status: Enrolling
Updated:  2/13/2018
Montefiore Medical Group- CHCC
2402
mi
from 98109
Bronx, NY
A Community Health Worker Home Intervention to Improve Pediatric Asthma Outcomes
A Randomized Controlled Trial of a Community Health Worker Home-Based Asthma Intervention
Status: Enrolling
Updated: 2/13/2018
Montefiore Medical Group- CHCC
2402
mi
from 98109
Bronx, NY
Click here to add this to my saved trials